Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scottish Postmenopausal Chemo-Endocrine Trial
NCT00002581Phase 3Completed
- Sponsor
- Scottish Cancer Therapy Network
- Start
- Jun 1993
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide, methotrexate and fluorouracil in breast cancer (2 arms), sponsored by Scottish Cancer Therapy Network. Started Jun 1993; status: completed.
02
Drugs
cyclophosphamidemethotrexatefluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002581.